Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 3.58
Key Takeaways
Risk factor
Fair trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very weak growth
Data is available to registered users only
Data is available to registered users only
About
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology,...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBIT
Data is available to registered users only
Buy
Sell